门脉高压症断流术后上消化道再出血的外科治疗探讨

目的探讨门脉高压症断流术后上消化道再出血的外科治疗方法及其疗效.方法对(1999-2000)年本科收治的34例门脉高压症断流术后上消化道再出血的病人行外科治疗及疗效分析.其中肝功能Child A组10级,B级18例,C级6例.治疗前钡餐或胃镜检查确诊.结果有14例行非手术外科治疗,2例经药物治疗止血;4例行胃镜下食道静脉套扎(EVL)止血,效果较好;6例行食管胃底曲张静脉脉硬化剂注射,2例行三腔二囊管止血,疗效不确切,再出血率62.5%(5/8).20便行手术治疗,9例行肠腔分流,2例(2/9)术后再次发生上消化道出血;术中食管胃底曲张静脉缝扎1例,食管胃底曲张静脉硬化剂注射2例,术后均再次出现上消化道出血;贲门血管再次离断2例,改良食管下段横断术3例,术后近远期疗效均可;贲门周围血管离断加肠腔分流水2例,术后有1例上消化道再出血.结论胃镜下食道静脉套扎术在非手术止血中效果较好,适合于不不宜手术的病人.手术治疗常选肠腔分流.对前次断流不彻底需再次断流,再次断流门静脉压仍高,则考虑行断流加分流.     

三氧化二砷对人脐静脉内皮细胞中蛋白激酶C活性和白细胞介素-15分泌、表达的影响及其临床意义

目的 通过研究三氧化二砷(As2O3)对人脐静脉内皮细胞(HUVEC)中蛋白激酶C(PKC)活性和白细胞介素(IL)-15表达和分泌的影响,探讨内皮细胞在As2O3抑制白血病或肿瘤中的作用。方法用不同浓度的As2O3作用于培养的HUVEC细胞,测定其生长情况、胞膜和胞浆PKC活性以及对IL-15基因表达和分泌的影响。结果0.25 μmol／L~50 μmol／L的.As2O3均抑制HUVEC细胞的增殖(P<0.01),随着药物浓度或作用时间的增加,细胞逐渐死亡。在As2O3作用细胞4 h测定胞浆和胞膜的PKC活性,两者在不同浓度作用下活性水平均得到提升(P<0.01),但胞膜的活性上升幅度更大。在As2O3的测定浓度范围内,PKC的活性水平与As2O3的浓度呈正相关。1、5、16 μmol／L的As2O3导致IL-15基因表达和分泌水平的增加(P<0.01),并呈浓度依赖性关系。结论As2O3可能是通过激活内皮细胞的PKC活性,促进IL-15或其他细胞因子的分泌,来抑制白血病或肿瘤发展的。     

USEFULNESS OF EUS IN PORTAL HYPERTENSION WITH ESOPHAGEAL VARICES

We investigated the relationship between esophageal varices and the collaterals by endoscopy and endoscopic ultrasound (20 MHz ultrasonic miniprobe; UMP). Moreover, we investigated the correlation between the collaterals around the esophagus and recurrence of esophageal varices in patients with portal hypertension who had undergone EIS. The collaterals were divided into two groups: peri‐esophageal collateral veins (peri‐ECVs) and para‐esophageal collateral veins (para‐ECVs). These were scored as mild or severe according to the stage of development. According to endoscopy, the varix form was significantly larger in severe the peri‐ECVs group than in mild the peri‐ECVs group. The prevalence of perforating veins increased according to the varix form. With regard to variceal recurrence, in patients with variceal recurrences, UMP findings included a significantly higher incidence of severe peri‐ECVs, a significantly larger diameter of perforating veins compared with patients without recurrence. In conclusion, the presence of severe peri‐ECVs and large perforating veins in the esophageal wall strongly correlates with occurrence and recurrence of esophageal varices in patients with portal hypertension. An understanding of these UMP abnormalities on the basis of hemodynamics around the esophagus is thought to be important for management of esophageal varices in patients with portal hypertension.     

TH胶胃冠状静脉栓塞术治疗门脉高压症

11例TH胶胃冠状静脉栓塞术临床治疗结果表明:(1)11例中的4例急性上消化道大出血患者均在12h左右出血基本停止,随访近一年未再发生出血现象。(2)10例半年后复查肝功能均有不同程度改善。(3)一年后复查食道钡餐透视X线平片发现8例患者食道静脉曲张有不同程度减轻。(4)11例中1例因术中急性肝功能衰竭死亡。因此我们认为此术式操作简便,手术创伤小、较易推广,是治疗门脉高压症合并食管胃底静脉曲张出血的一种有效方法。     

MRI visualization of the aortic nipple

The aortic nipple, a small “pseudotumor” adjacent to the aortic arch, is the left superior intercostal vein. In our series of 40 patients it was demonstrated in six; all had a right upper thoracic mass and four had a superior vena caval syndrome. Coronal magnetic resonance, images (MRI) of the thorax were superior to all other imaging methods in demonstrating the nipple. It is concluded that in patients with masses in the right upper chest, coronal MR chest examinations are valuable in demonstrating an aortic nipple, a sign of impending present superior vena caval or innominate, vein obstruction.     

全植入式药泵行肝血管灌注治疗晚期肝癌

对２４例不能切除的晚期肝癌采用完全植入式药泵行肝动脉和门静脉双灌注化疗。结果：部分缓解（ＰＲ）１５例（６２．５％），稳定（Ｓ）８例（３３．３％），进展（Ｐ）１例。平均生存期为９．１７月，半年生存率为６６．７％，１年为２５％。在ＡＦＰ＞４００μｇ／Ｌ的１０例中，５例下降。     

联合断流术治疗食管静脉曲张出血的临床研究及远期疗效观察

自1981年1月以来,行联合断流术治疗门脉高压症食管静脉曲张出血102例,手术死亡率为6.9%。随访1～8年的生存率为85.7%,食管静脉曲张减轻或消失者为90%,未发现肝性脑病症状。远期死亡9例(14.3%),再出血4例(6.3%)。资料表明,这种手术既阻断了胃外又阻断了胃壁内的门-奇静脉交通血流,止血效果肯定而持久。由于未降低门静脉压力,故有利于维持肝脏的血流灌注。肝功能状况是决定治疗效果的主要因素。文章提出了选择手术适应证的条件。     

Die verwendung der autologen vena femoralis bei vena-cava-superior-thrombose

We report on a 52-year old male patient who underwent implantation of an insulin pump because he had diabetes and in whom superior vena cava syndrome developed as a long-term complication. After unsuccessful lysis therapy superficial femoral vein was implanted to form a bypass from the internal jugular vein to the right atrium. The postoperative course was uneventful from the aspects of both the bypass and the leg after explantation of the superficial femoral vein. The bypass is still patent 7 months after the operation, and the patient has no symptoms. Autogenous superficial femoral vein can be used successfully in the reconstruction of large venous vessels. It should be the graft of choice for young patients with benign diseases. We compare our result and those obtained with different substitutes described in the literature that have been used for reconstruction in superior vena cava syndrome.

---

Die verwendung der autologen vena femoralis bei vena-cava-superior-thromboseFallbericht mit literaturübersicht

Zusammenfassung Bei einem 52jährigen, männlichen Patienten trat nach Implantation einer Insulinpumpe als Spätkomplikation eine Thrombose der Vena cava superior auf. Nach erfolgloser Lysetherapie wurde ein Venajugularis-rechtsatrialer-Venenbypass mit autologer Vena femoralis durchgeführt. Der postoperative Heilungsverlauf war sowohl von Seiten des gefäßrekonstruktiven Eingriffs, als auch von Seiten der Venenentnahmestelle komplikationslos. Der Bypass ist 7 Monate postoperativ offen und der Patient beschwerdefrei. Die autologe Vena femoralis eignet sich zur Rekonstruktion großer venöser Gefäße ausgezeichnet. Sie sollte v. a. bei benignen Prozessen und jüngeren Patienten als autologes Bypassmaterial dem Kunststoff vorgezogen werden. Das Ergebnis wird mit verschiedenen Gefäßsubstituten, die bei Verschluß der oberen Hohlvene verwendet werden, verglichen.

     

猪门静脉回流阻断模型内毒素的移位

【目的】拟在猪的肠血管阻断模型中探讨门静脉回流阻断肠淤血可能造成的内毒素移位和肿瘤坏死因子释放。【方法】采用种群相近体质量22～25kg雌性小猪8只，无感染症状。分离门静脉和肝后下腔静脉分别阻断、然后开放各60min．观察血压、心率，阻断前和开放60min各取回肠末端小肠全层行光镜、电镜检查，测定门、颈静脉血内毒素及肿瘤坏死因子（TNF—α）含量。【结果】门静脉和肝后下腔静脉阻断后，肠淤血、水肿，并随时间延长而加重，光镜检查表明实验后肠粘膜和腺体明显损伤，电镜检查表明细胞超微结构轻微异常。阻断前后的血内毒素、TNF—α含量无显著性差异。【结论】①肠静脉回流阻断60min引起的肠道淤血可导致肠粘膜屏障损伤。②在60min内肠淤血性的损伤不会引起肠腔内内毒素的大量移位及TNF—α的释放。